Literature DB >> 19525593

Type 2 diabetes mellitus accompanied by isolated adrenocorticotropic hormone deficiency and gastric cancer.

Yuji Kamiya1, Masami Murakami.   

Abstract

A 69-year-old man with type 2 diabetes mellitus was admitted to our hospital because of appetite loss, nausea and vomiting. Gastroscopy revealed gastric cancer. Levels of plasma cortisol were decreased. Neither adrenocorticotropic hormone (ACTH) nor cortisol levels were adequately increased in response to a mixed intravenous administration of corticotropin-releasing hormone, growth hormone-releasing hormone, thyrotropin-releasing hormone and lutenizing hormone-releasing hormone, although other pituitary hormones were increased adequately. He was diagnosed as having isolated ACTH deficiency (IAD). Anti-pituitary antibody and anti-parietal cell antibody were positive. At least in part, these antibodies may play pathogenic roles of development of IAD and gastric cancer.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19525593     DOI： 10.2169/internalmedicine.48.1972

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


  8 in total

1.  Adrenal Insufficiency as a Paraneoplastic Syndrome in Gastric Adenocarcinoma.

Authors:  Bilal Farooqi; Hemant Goyal; Harold Katner
Journal:  J Gastrointest Cancer       Date:  2016-12

2.  A patient with isolated adrenocorticotropin deficiency presenting with repetitive oesophageal ulcer and stenosis.

Authors:  Hiroyuki Tamiya; Akihisa Ishikawa; Shinya Mano; Toshiro Kamoshida; Shinji Hirai; Noriko Chikatsu; Yuji Oka
Journal:  BMJ Case Rep       Date:  2010-12-29

3.  Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome.

Authors:  Hironori Bando; Genzo Iguchi; Keitaro Kanie; Hitoshi Nishizawa; Ryusaku Matsumoto; Yasunori Fujita; Yukiko Odake; Kenichi Yoshida; Kentaro Suda; Hidenori Fukuoka; Keiko Tanaka; Wataru Ogawa; Yutaka Takahashi
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

Review 4.  Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation.

Authors:  Sriram Gubbi; Fady Hannah-Shmouni; Joseph G Verbalis; Christian A Koch
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2019-12-12       Impact factor: 4.690

5.  Two Cases of anti-PIT-1 Hypophysitis Exhibited as a Form of Paraneoplastic Syndrome not Associated With Thymoma.

Authors:  Keitaro Kanie; Genzo Iguchi; Megumi Inuzuka; Kentaro Sakaki; Hironori Bando; Shin Urai; Hiroki Shichi; Yasunori Fujita; Ryusaku Matsumoto; Kentaro Suda; Masaaki Yamamoto; Hidenori Fukuoka; Takao Taniguchi; Wataru Ogawa; Yutaka Takahashi
Journal:  J Endocr Soc       Date:  2020-12-31

6.  Effects of tofogliflozin on adrenocorticotropic hormone, renin and aldosterone, and cortisol levels in elderly patients with diabetes mellitus: A retrospective study of a patient cohort.

Authors:  Toshihiro Higashikawa; Tomohiko Ito; Takurou Mizuno; Keiichirou Ishigami; Kengo Kuroki; Naoto Maekawa; Daisuke Usuda; Takuro Morita; Kazu Hamada; Susumu Takagi; Kento Takeshima; Shinya Yamada; Ryusho Sangen; Toshihide Izumida; Hideyuki Mori; Jun Kiyosawa; Atsushi Saito; Masaharu Iguchi; Takeshi Nakahashi; Yuji Kasamaki; Akihiro Fukuda; Tsugiyasu Kanda; Masashi Okuro
Journal:  Medicine (Baltimore)       Date:  2021-11-12       Impact factor: 1.817

7.  Isolated adrenocorticotropic hormone deficiency development during chemotherapy for gastric cancer: a case report.

Authors:  Jun Kinoshita; Shinnosuke Higashino; Sachio Fushida; Katsunobu Oyama; Toshifumi Watanabe; Koichi Okamoto; Keishi Nakamura; Hiroyuki Takamura; Itasu Ninomiya; Hirohisa Kitagawa; Takashi Fujimura; Tetsuo Ohta
Journal:  J Med Case Rep       Date:  2014-03-05

8.  Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.

Authors:  Keitaro Kanie; Genzo Iguchi; Hironori Bando; Shin Urai; Hiroki Shichi; Yasunori Fujita; Ryusaku Matsumoto; Kentaro Suda; Masaaki Yamamoto; Hidenori Fukuoka; Wataru Ogawa; Yutaka Takahashi
Journal:  Cancer Immunol Immunother       Date:  2021-05-11       Impact factor: 6.968
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.